drugset / Trial / NCT07282886
VENTURI (VENTilation Using Respiratory Imaging)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to enroll participants with uncontrolled asthma to evaluate the large and small airways and drug delivery utilizing two study drugs: * Beclometasone dipropionate/Formoterol fumarate dihydrate/Glycopyrronium bromide (BDP/FF/G) or Trimbow * Fluticasone furoate/Umeclidinium/Vilanterol (FluF/UMEC/VI ) or Trelegy Ellipta
Timeline
- Start
- 2026-03-15
- Primary completion
- 2028-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate | Unknown | 6 ug | Inhaled |
| Subject | Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate | Unknown | 12.5 ug | Inhaled |
| Subject | Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate | Unknown | 100 ug | Inhaled |
| Comparator | Fluticasone Furoate/Umeclidinium/Vilanterol | Unknown | 25 ug | Inhaled |
| Comparator | Fluticasone Furoate/Umeclidinium/Vilanterol | Unknown | 62.5 ug | Inhaled |
| Comparator | Fluticasone Furoate/Umeclidinium/Vilanterol | Unknown | 100 ug | Inhaled |